Skip to main content
Darell Bigner, MD, Neurology, Durham, NC

DarellDotyBignerMD

Neurology • Durham, NC

Professor, Pathology, Duke University School of Medicine

Join to view full profile

Dr. Bigner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bigner's full profile

Already have an account?

  • Office

    Duke Medical Ctr
    # 3156
    Durham, NC 27710
    Phone+1 919-684-5018
    Fax+1 919-684-6458

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Surgery, 1970 - 1970
  • Duke University Hospital
    Duke University HospitalResidency, Neurological Surgery, 1966 - 1968
  • Duke University Hospital
    Duke University HospitalInternship, Transitional Year, 1965 - 1966
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1965

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1966 - 2025
  • GA State Medical License
    GA State Medical License 1965 - 1975

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Recurrent Glioblastoma Treated with Recombinant Poliovirus  
    Darell Bigner, MD, The New England Journal of Medicine
  • The Genomic Landscape of TERT Promoter Wildtype-IDH Wildtype Glioblastoma  
    Daniel B. Loriaux, Darel D. Bigner, Fausto J. Rodriguez, Hai Yan, Bil H. Diplas, Henry S. Friedman, Roger E. McLendon, Nature

Press Mentions

  • New Brain Tumor Drug Hits Market 16 Years After Duke Neurosurgeon's Discovery: ' Excited'
    New Brain Tumor Drug Hits Market 16 Years After Duke Neurosurgeon's Discovery: ' Excited'August 27th, 2024
  • FDA Gives Patients Hope After Approving Brain Cancer Drug with Duke Ties
    FDA Gives Patients Hope After Approving Brain Cancer Drug with Duke TiesAugust 27th, 2024
  • FDA Approves Brain Cancer Drug with Duke Ties Giving Patients Hope
    FDA Approves Brain Cancer Drug with Duke Ties Giving Patients HopeAugust 26th, 2024
  • Join now to see all

Grant Support

  • Neuro-OncologyNational Cancer Institute2010–2012
  • SRC On Primary Tumors Of The CNSNational Institute Of Neurological Disorders And Stroke2009–2012
  • Ind, Regulatory And BioinformaticsNational Institute Of Neurological Disorders And Stroke2009–2012
  • Administrative CoreNational Institute Of Neurological Disorders And Stroke2009–2012
  • Brain Tumors - Immunological And Biological StudiesNational Cancer Institute2001–2012
  • NeurooncologyNational Cancer Institute2005–2009
  • Spore In Brain CancerNational Cancer Institute2004–2009
  • Core--Developmental Research ProgramNational Cancer Institute2004–2008
  • Core--Career Development ProgramNational Cancer Institute2004–2008
  • SRC On Primary And Metastatic Tumors Of The CNSNational Institute Of Neurological Disorders And Stroke1994–2008
  • Administration Support Core 5National Cancer Institute2004
  • Spore In Brain CancerNational Cancer Institute2002–2003
  • Rapid Development Of Glioma Targeting Reagents For TherapyNational Cancer Institute2002
  • Comprehensive Cancer Center Core Support GrantNational Cancer Institute2002
  • Clinical Trials With Solid Intracranial Tumors &Neoplastic MeningitisNational Institute Of Neurological Disorders And Stroke1999–2002
  • Core--Immunoincompetent Rodent &Biohazard FacilityNational Cancer Institute1999–2002
  • Core--General Laboratory And Animal SupportNational Institute Of Neurological Disorders And Stroke1994–2002
  • Brain Tumors--Immunological And Biological StudiesNational Cancer Institute1992–2000
  • Core--Cancer Center Isolation FacilityNational Cancer Institute1996–1998
  • Research Training In Neuro-OncologyNational Institute Of Neurological Disorders And Stroke1992–1996
  • Intrathecal Therapy Of Melanoma Neoplastic MeningitisNational Cancer Institute1991–1993
  • SRC On Malignant Human Gliomas And MedulloblastomasNational Institute Of Neurological Disorders And Stroke1989–1993
  • Increased Delivery Of Monoclonal Antibody RadioimmunoatherapyNational Institute Of Neurological Disorders And Stroke1989–1993
  • Brain Tumors: Immunological And Biological StudiesNational Cancer Institute1988–1991
  • Malignant Human Gliomas And MedulloblastomaNational Institute Of Neurological Disorders And Stroke1985–1988
  • Brain Tumors: Immunological And Biological StudiesNational Cancer Institute1985–1987
  • Conference On Brain Tumor Research And TherapyNational Institute Of Neurological Disorders And Stroke1985

Dr. Darell Bigner, Dr. Darell Bigner, MD, Dr. D Bigner, Dr. Darell Doty Bigner